Latest News & Features
Asia
The Indian Patent Office has rejected one of US drug maker Gilead’s patent applications to cover hepatitis C drug Sovaldi (sofosbuvir), in a decision that may decrease the blockbuster’s cost in the country. 16 January 2015
Americas
California-based pharmaceutical company Depomed has revealed it will acquire the IP rights to Janssen Pharmaceuticals’ painkiller drug Nucynta (tapentadol) for $1.05 billion. 16 January 2015
Asia
Cipla has appealed against a decision by the Delhi High Court that blocked the generic drug maker from marketing copies of Novartis’s respiratory drug Onbrez (indacaterol) in India. 16 January 2015
Asia
The Delhi High Court has issued a interim injunction stopping Indian generic drug maker Cipla from selling copies of Novartis’s respiratory drug Onbrez (indacaterol) in the country. 15 January 2015
Americas
The US Patent and Trademark Office has rejected several petitions that challenged a patent covering Jazz Pharmaceuticals’ narcolepsy drug Xyrem (sodium oxybate). 15 January 2015
Big Pharma
The Federal Court of Justice of Germany, the country’s highest court, has rejected an appeal from AstraZeneca in which the pharmaceutical company claimed that a patent used in its drug Seroquel XR (quetiapine) is valid. 14 January 2015
Americas
The US Court of Appeals for the Federal Circuit has affirmed a lower court’s decision that manufacturer W L Gore & Associates infringed a patent owned by medical device maker Bard Peripheral Vascular, bringing to an end a dispute that stems from more than 40 years ago. 14 January 2015
Europe
UK regulatory body the Medicines and Healthcare and Products Regulatory Agency has successfully taken down more than 1,600 websites, some of which were selling counterfeit drugs. 13 January 2015
Europe
Biopharmaceutical company Shire has agreed a multi-billion pound deal to buy US business NPS Pharmaceuticals, which operates in the same industry. 12 January 2015
Asia
Glenmark Pharmaceuticals has been handed victory after the Indian Patent Office reversed a ruling that had granted a patent to US company Abbott Biotechnology for its anti-arthritis drug Humira (adalimumab). 9 January 2015